Display options
Share it on

Clin Case Rep. 2015 Sep;3(9):728-30. doi: 10.1002/ccr3.327. Epub 2015 Jul 15.

Plerixafor as a salvage mobilization strategy for haploidentical peripheral blood allogeneic stem cell transplantation.

Clinical case reports

Michelle Nadeau, Laeth George, Andrew M Yeager, Faiz Anwer, Ali McBride

Affiliations

  1. Department of Pharmacy, Yale-New Haven Hospital New Haven, Connecticut.
  2. The University of Arizona Tucson, Arizona.
  3. Division of Hematology, Oncology, Blood & Marrow Transplantation, Department of Medicine, University of Arizona Tucson, Arizona.
  4. Department of Pharmacy, The University of Arizona Cancer Center Tucson, Arizona.

PMID: 26401275 PMCID: PMC4574786 DOI: 10.1002/ccr3.327

Abstract

In allogeneic stem cell mobilization, peripheral blood stem cell mobilization with filgrastim can be considered standard of care. Poor mobilizers may be at risk for inadequate stem cell collection during apheresis. He we present a successful case of salvage plerixafor use with filgrastim in a haploidentical identical transplant patient.

Keywords: CLL; mobilization; plerixafor; stem cell transplant

References

  1. Br J Haematol. 2011 Apr;153(1):66-75 - PubMed
  2. Curr Opin Oncol. 2012 Mar;24(2):191-6 - PubMed
  3. Transfusion. 2013 Oct;53(10):2314-26 - PubMed
  4. Bone Marrow Transplant. 2011 May;46(5):762-3 - PubMed
  5. Blood. 2011 Dec 15;118(25):6580-90 - PubMed
  6. Biol Blood Marrow Transplant. 2014 Mar;20(3):295-308 - PubMed
  7. Blood. 2005 Sep 1;106(5):1867-74 - PubMed
  8. Biol Blood Marrow Transplant. 2014 Sep;20(9):1262-73 - PubMed
  9. J Clin Oncol. 2004 Mar 15;22(6):1095-102 - PubMed

Publication Types